CA2513028A1 - Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement - Google Patents

Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement Download PDF

Info

Publication number: CA2513028A1
Authority: CA; Canada
Prior art keywords: amniotic fluid; fetal; rna; fetal rna; sample
Prior art date: 2005-07-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2513028

Other languages

English (en)

Inventor

Diana W. Bianchi

Paige B. Larrabee

Kirby L. Johnson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

TUFTS-NEW ENGLAND MEDICAL CENTER

Original Assignee

TUFTS-NEW ENGLAND MEDICAL CENTER

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-22

Filing date

2005-07-22

Publication date

2007-01-22

2005-07-22 Application filed by TUFTS-NEW ENGLAND MEDICAL CENTER filed Critical TUFTS-NEW ENGLAND MEDICAL CENTER

2005-07-22 Priority to CA 2513028 priority Critical patent/CA2513028A1/fr

2007-01-22 Publication of CA2513028A1 publication Critical patent/CA2513028A1/fr

Status Abandoned legal-status Critical Current

Links

230000001605 fetal effect Effects 0.000 title claims abstract description 285
210000004381 amniotic fluid Anatomy 0.000 title claims abstract description 225
230000014509 gene expression Effects 0.000 title claims abstract description 189
210000003754 fetus Anatomy 0.000 title claims abstract description 159
238000000034 method Methods 0.000 claims abstract description 210
238000004458 analytical method Methods 0.000 claims abstract description 75
238000012360 testing method Methods 0.000 claims abstract description 54
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 42
201000010099 disease Diseases 0.000 claims abstract description 37
241000282414 Homo sapiens Species 0.000 claims abstract description 36
238000003793 prenatal diagnosis Methods 0.000 claims abstract description 34
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 293
239000000523 sample Substances 0.000 claims description 266
108090000623 proteins and genes Proteins 0.000 claims description 156
150000007523 nucleic acids Chemical class 0.000 claims description 108
238000009396 hybridization Methods 0.000 claims description 98
108020004707 nucleic acids Proteins 0.000 claims description 86
102000039446 nucleic acids Human genes 0.000 claims description 86
230000002068 genetic effect Effects 0.000 claims description 76
108020004999 messenger RNA Proteins 0.000 claims description 68
238000010804 cDNA synthesis Methods 0.000 claims description 49
239000003795 chemical substances by application Substances 0.000 claims description 49
108020004635 Complementary DNA Proteins 0.000 claims description 48
239000002299 complementary DNA Substances 0.000 claims description 48
239000012530 fluid Substances 0.000 claims description 46
239000000463 material Substances 0.000 claims description 43
108020004394 Complementary RNA Proteins 0.000 claims description 41
239000003184 complementary RNA Substances 0.000 claims description 41
230000027455 binding Effects 0.000 claims description 36
238000002372 labelling Methods 0.000 claims description 31
239000007850 fluorescent dye Substances 0.000 claims description 27
230000008569 process Effects 0.000 claims description 19
239000000758 substrate Substances 0.000 claims description 19
208000031404 Chromosome Aberrations Diseases 0.000 claims description 18
230000002159 abnormal effect Effects 0.000 claims description 18
238000010195 expression analysis Methods 0.000 claims description 18
239000013614 RNA sample Substances 0.000 claims description 14
230000008175 fetal development Effects 0.000 claims description 14
239000003161 ribonuclease inhibitor Substances 0.000 claims description 13
208000036830 Normal foetus Diseases 0.000 claims description 12
108700029231 Developmental Genes Proteins 0.000 claims description 11
102000004190 Enzymes Human genes 0.000 claims description 11
108090000790 Enzymes Proteins 0.000 claims description 11
239000000203 mixture Substances 0.000 claims description 11
238000002073 fluorescence micrograph Methods 0.000 claims description 10
208000012239 Developmental disease Diseases 0.000 claims description 7
239000000872 buffer Substances 0.000 claims description 7
230000002759 chromosomal effect Effects 0.000 claims description 7
238000010191 image analysis Methods 0.000 claims description 7
230000005291 magnetic effect Effects 0.000 claims description 7
238000003384 imaging method Methods 0.000 claims description 6
239000011534 wash buffer Substances 0.000 claims description 5
239000011859 microparticle Substances 0.000 claims description 4
238000012258 culturing Methods 0.000 claims 3
238000011161 development Methods 0.000 abstract description 20
238000002955 isolation Methods 0.000 abstract description 10
230000036541 health Effects 0.000 abstract description 6
238000012544 monitoring process Methods 0.000 abstract description 5
230000012010 growth Effects 0.000 abstract description 4
238000012216 screening Methods 0.000 abstract description 4
210000004027 cell Anatomy 0.000 description 56
238000001514 detection method Methods 0.000 description 36
108010076876 Keratins Proteins 0.000 description 35
102000011782 Keratins Human genes 0.000 description 33
108020004414 DNA Proteins 0.000 description 27
238000003491 array Methods 0.000 description 27
210000000349 chromosome Anatomy 0.000 description 26
230000018109 developmental process Effects 0.000 description 23
108091034117 Oligonucleotide Proteins 0.000 description 22
238000002493 microarray Methods 0.000 description 22
102000004169 proteins and genes Human genes 0.000 description 22
238000006243 chemical reaction Methods 0.000 description 19
241000521257 Hydrops Species 0.000 description 17
206010030113 Oedema Diseases 0.000 description 17
230000003321 amplification Effects 0.000 description 17
238000003199 nucleic acid amplification method Methods 0.000 description 17
239000000975 dye Substances 0.000 description 16
238000002474 experimental method Methods 0.000 description 15
230000000295 complement effect Effects 0.000 description 14
238000000605 extraction Methods 0.000 description 14
238000013518 transcription Methods 0.000 description 14
230000035897 transcription Effects 0.000 description 14
125000003729 nucleotide group Chemical group 0.000 description 13
239000002253 acid Substances 0.000 description 12
239000002773 nucleotide Substances 0.000 description 12
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
108091028043 Nucleic acid sequence Proteins 0.000 description 11
108010083644 Ribonucleases Proteins 0.000 description 11
102000006382 Ribonucleases Human genes 0.000 description 11
238000005119 centrifugation Methods 0.000 description 11
230000008774 maternal effect Effects 0.000 description 11
-1 phycoeiythrin Chemical compound 0.000 description 11
239000000047 product Substances 0.000 description 11
230000003252 repetitive effect Effects 0.000 description 11
239000004094 surface-active agent Substances 0.000 description 11
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
108010063954 Mucins Proteins 0.000 description 10
238000002669 amniocentesis Methods 0.000 description 10
238000005516 engineering process Methods 0.000 description 10
239000013615 primer Substances 0.000 description 10
238000011160 research Methods 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
102100034343 Integrase Human genes 0.000 description 9
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 9
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
230000005856 abnormality Effects 0.000 description 9
230000006870 function Effects 0.000 description 9
230000035935 pregnancy Effects 0.000 description 9
208000011580 syndromic disease Diseases 0.000 description 9
206010008805 Chromosomal abnormalities Diseases 0.000 description 8
208000032170 Congenital Abnormalities Diseases 0.000 description 8
102000015728 Mucins Human genes 0.000 description 8
238000002123 RNA extraction Methods 0.000 description 8
150000007513 acids Chemical class 0.000 description 8
238000013459 approach Methods 0.000 description 8
230000008859 change Effects 0.000 description 8
229940088598 enzyme Drugs 0.000 description 8
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 8
239000012520 frozen sample Substances 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
230000001225 therapeutic effect Effects 0.000 description 8
102000004888 Aquaporin 1 Human genes 0.000 description 7
108090001004 Aquaporin 1 Proteins 0.000 description 7
206010010356 Congenital anomaly Diseases 0.000 description 7
241000272168 Laridae Species 0.000 description 7
238000003556 assay Methods 0.000 description 7
108091092259 cell-free RNA Proteins 0.000 description 7
230000007423 decrease Effects 0.000 description 7
239000010410 layer Substances 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
238000003860 storage Methods 0.000 description 7
230000005945 translocation Effects 0.000 description 7
108010063290 Aquaporins Proteins 0.000 description 6
108020004711 Nucleic Acid Probes Proteins 0.000 description 6
230000007698 birth defect Effects 0.000 description 6
230000000903 blocking effect Effects 0.000 description 6
230000015556 catabolic process Effects 0.000 description 6
230000002559 cytogenic effect Effects 0.000 description 6
230000003247 decreasing effect Effects 0.000 description 6
238000006731 degradation reaction Methods 0.000 description 6
239000003814 drug Substances 0.000 description 6
238000007710 freezing Methods 0.000 description 6
230000008014 freezing Effects 0.000 description 6
210000004072 lung Anatomy 0.000 description 6
238000005259 measurement Methods 0.000 description 6
239000003068 molecular probe Substances 0.000 description 6
239000002853 nucleic acid probe Substances 0.000 description 6
210000002826 placenta Anatomy 0.000 description 6
201000007532 polyhydramnios Diseases 0.000 description 6
239000007787 solid Substances 0.000 description 6
239000000126 substance Substances 0.000 description 6
238000005406 washing Methods 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
208000026350 Inborn Genetic disease Diseases 0.000 description 5
101100384865 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cot-1 gene Proteins 0.000 description 5
208000036878 aneuploidy Diseases 0.000 description 5
229960002685 biotin Drugs 0.000 description 5
235000020958 biotin Nutrition 0.000 description 5
239000011616 biotin Substances 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
239000012634 fragment Substances 0.000 description 5
208000016361 genetic disease Diseases 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012545 processing Methods 0.000 description 5
238000012552 review Methods 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
210000004291 uterus Anatomy 0.000 description 5
102000010637 Aquaporins Human genes 0.000 description 4
206010041092 Small for dates baby Diseases 0.000 description 4
108020000999 Viral RNA Proteins 0.000 description 4
210000002593 Y chromosome Anatomy 0.000 description 4
238000007792 addition Methods 0.000 description 4
230000004075 alteration Effects 0.000 description 4
231100001075 aneuploidy Toxicity 0.000 description 4
230000002596 correlated effect Effects 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
230000007547 defect Effects 0.000 description 4
206010012601 diabetes mellitus Diseases 0.000 description 4
229940079593 drug Drugs 0.000 description 4
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
230000031864 metaphase Effects 0.000 description 4
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
238000010369 molecular cloning Methods 0.000 description 4
238000000746 purification Methods 0.000 description 4
230000008707 rearrangement Effects 0.000 description 4
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
239000000243 solution Substances 0.000 description 4
238000010186 staining Methods 0.000 description 4
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 4
230000014616 translation Effects 0.000 description 4
238000002604 ultrasonography Methods 0.000 description 4
108091023037 Aptamer Proteins 0.000 description 3
102000004363 Aquaporin 3 Human genes 0.000 description 3
108090000991 Aquaporin 3 Proteins 0.000 description 3
201000010374 Down Syndrome Diseases 0.000 description 3
108091007413 Extracellular RNA Proteins 0.000 description 3
102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 3
108010024164 HLA-G Antigens Proteins 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 3
201000009928 Patau syndrome Diseases 0.000 description 3
108091034057 RNA (poly(A)) Proteins 0.000 description 3
108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
206010044686 Trisomy 13 Diseases 0.000 description 3
208000006284 Trisomy 13 Syndrome Diseases 0.000 description 3
241000700605 Viruses Species 0.000 description 3
108700029634 Y-Linked Genes Proteins 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
239000011324 bead Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
210000004252 chorionic villi Anatomy 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
239000013068 control sample Substances 0.000 description 3
210000004748 cultured cell Anatomy 0.000 description 3
238000007405 data analysis Methods 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
210000002219 extraembryonic membrane Anatomy 0.000 description 3
238000001215 fluorescent labelling Methods 0.000 description 3
238000013467 fragmentation Methods 0.000 description 3
238000006062 fragmentation reaction Methods 0.000 description 3
230000008303 genetic mechanism Effects 0.000 description 3
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
230000006872 improvement Effects 0.000 description 3
210000000936 intestine Anatomy 0.000 description 3
238000011835 investigation Methods 0.000 description 3
238000011005 laboratory method Methods 0.000 description 3
239000003550 marker Substances 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
238000002966 oligonucleotide array Methods 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
241000894007 species Species 0.000 description 3
230000003595 spectral effect Effects 0.000 description 3
238000007619 statistical method Methods 0.000 description 3
125000005504 styryl group Chemical group 0.000 description 3
239000013595 supernatant sample Substances 0.000 description 3
238000010257 thawing Methods 0.000 description 3
238000013519 translation Methods 0.000 description 3
238000010200 validation analysis Methods 0.000 description 3
238000012800 visualization Methods 0.000 description 3
230000036266 weeks of gestation Effects 0.000 description 3
229920000936 Agarose Polymers 0.000 description 2
108090001008 Avidin Proteins 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108700039887 Essential Genes Proteins 0.000 description 2
108091060211 Expressed sequence tag Proteins 0.000 description 2
208000002757 Fetofetal Transfusion Diseases 0.000 description 2
108010009066 Gastric Mucins Proteins 0.000 description 2
102000009338 Gastric Mucins Human genes 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000972286 Homo sapiens Mucin-4 Proteins 0.000 description 2
101000972282 Homo sapiens Mucin-5AC Proteins 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
208000017924 Klinefelter Syndrome Diseases 0.000 description 2
108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
PQMWYJDJHJQZDE-UHFFFAOYSA-M Methantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 PQMWYJDJHJQZDE-UHFFFAOYSA-M 0.000 description 2
102100022496 Mucin-5AC Human genes 0.000 description 2
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108091036407 Polyadenylation Proteins 0.000 description 2
108010046983 Ribonuclease T1 Proteins 0.000 description 2
108091028664 Ribonucleotide Proteins 0.000 description 2
108010000605 Ribosomal Proteins Proteins 0.000 description 2
102000002278 Ribosomal Proteins Human genes 0.000 description 2
208000026928 Turner syndrome Diseases 0.000 description 2
210000001015 abdomen Anatomy 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
102000013529 alpha-Fetoproteins Human genes 0.000 description 2
108010026331 alpha-Fetoproteins Proteins 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
210000003484 anatomy Anatomy 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
210000002459 blastocyst Anatomy 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 2
239000000298 carbocyanine Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
238000000701 chemical imaging Methods 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000003086 colorant Substances 0.000 description 2
230000021615 conjugation Effects 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
230000003111 delayed effect Effects 0.000 description 2
230000029087 digestion Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
210000002257 embryonic structure Anatomy 0.000 description 2
230000007515 enzymatic degradation Effects 0.000 description 2
238000012869 ethanol precipitation Methods 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
230000005284 excitation Effects 0.000 description 2
210000004700 fetal blood Anatomy 0.000 description 2
239000000499 gel Substances 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
230000029795 kidney development Effects 0.000 description 2
239000003446 ligand Substances 0.000 description 2
230000007040 lung development Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
238000010208 microarray analysis Methods 0.000 description 2
230000003547 miosis Effects 0.000 description 2
229940051875 mucins Drugs 0.000 description 2
238000010606 normalization Methods 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
230000008520 organization Effects 0.000 description 2
230000005298 paramagnetic effect Effects 0.000 description 2
239000002245 particle Substances 0.000 description 2
230000037361 pathway Effects 0.000 description 2
230000009984 peri-natal effect Effects 0.000 description 2
239000012071 phase Substances 0.000 description 2
150000008300 phosphoramidites Chemical class 0.000 description 2
QWYZFXLSWMXLDM-UHFFFAOYSA-M pinacyanol iodide Chemical compound [I-].C1=CC2=CC=CC=C2N(CC)C1=CC=CC1=CC=C(C=CC=C2)C2=[N+]1CC QWYZFXLSWMXLDM-UHFFFAOYSA-M 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000037452 priming Effects 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
230000002685 pulmonary effect Effects 0.000 description 2
238000006862 quantum yield reaction Methods 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
206010038433 renal dysplasia Diseases 0.000 description 2
239000002336 ribonucleotide Substances 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
238000005070 sampling Methods 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000032258 transport Effects 0.000 description 2
206010053884 trisomy 18 Diseases 0.000 description 2
230000003827 upregulation Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
WWYNJERNGUHSAO-CULCCENASA-N (8r,9s,10r,13s,14s)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)(C(CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-CULCCENASA-N 0.000 description 1
208000010543 22q11.2 deletion syndrome Diseases 0.000 description 1
206010000234 Abortion spontaneous Diseases 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
208000008103 Amniotic Band Syndrome Diseases 0.000 description 1
241000567030 Ampulloclitocybe clavipes Species 0.000 description 1
241000713838 Avian myeloblastosis virus Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
208000032135 Birth Weight Diseases 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
101000600085 Caenorhabditis elegans Eukaryotic initiation factor 4A Proteins 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
108091061744 Cell-free fetal DNA Proteins 0.000 description 1
208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102100038530 Chorionic somatomammotropin hormone 2 Human genes 0.000 description 1
208000003449 Classical Lissencephalies and Subcortical Band Heterotopias Diseases 0.000 description 1
102100026735 Coagulation factor VIII Human genes 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 1
108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 1
239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000000018 DNA microarray Methods 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
241000252212 Danio rerio Species 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
208000000398 DiGeorge Syndrome Diseases 0.000 description 1
BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical class C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
206010014561 Emphysema Diseases 0.000 description 1
108010022894 Euchromatin Proteins 0.000 description 1
201000003542 Factor VIII deficiency Diseases 0.000 description 1
208000001362 Fetal Growth Retardation Diseases 0.000 description 1
208000001914 Fragile X syndrome Diseases 0.000 description 1
GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
208000008899 Habitual abortion Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
108010034791 Heterochromatin Proteins 0.000 description 1
101000956228 Homo sapiens Chorionic somatomammotropin hormone 2 Proteins 0.000 description 1
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
101000972273 Homo sapiens Mucin-7 Proteins 0.000 description 1
101001086862 Homo sapiens Pulmonary surfactant-associated protein B Proteins 0.000 description 1
101000612671 Homo sapiens Pulmonary surfactant-associated protein C Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
238000009015 Human TaqMan MicroRNA Assay kit Methods 0.000 description 1
208000006031 Hydrops Fetalis Diseases 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
238000002768 Kirby-Bauer method Methods 0.000 description 1
208000031942 Late Onset disease Diseases 0.000 description 1
208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
208000035752 Live birth Diseases 0.000 description 1
206010067508 Low birth weight baby Diseases 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
201000004246 Miller-Dieker lissencephaly syndrome Diseases 0.000 description 1
208000035022 Miller-Dieker syndrome Diseases 0.000 description 1
208000003445 Mouth Neoplasms Diseases 0.000 description 1
108010008707 Mucin-1 Proteins 0.000 description 1
102000007298 Mucin-1 Human genes 0.000 description 1
102100022492 Mucin-7 Human genes 0.000 description 1
208000034702 Multiple pregnancies Diseases 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
208000011623 Obstructive Lung disease Diseases 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
108010044843 Peptide Initiation Factors Proteins 0.000 description 1
102000005877 Peptide Initiation Factors Human genes 0.000 description 1
240000003888 Phoenix reclinata Species 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
208000008601 Polycythemia Diseases 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
201000010769 Prader-Willi syndrome Diseases 0.000 description 1
108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 1
102000007615 Pulmonary Surfactant-Associated Protein A Human genes 0.000 description 1
108010007127 Pulmonary Surfactant-Associated Protein D Proteins 0.000 description 1
206010037407 Pulmonary hypoplasia Diseases 0.000 description 1
102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 description 1
102100040971 Pulmonary surfactant-associated protein C Human genes 0.000 description 1
102100027845 Pulmonary surfactant-associated protein D Human genes 0.000 description 1
108010066717 Q beta Replicase Proteins 0.000 description 1
238000012341 Quantitative reverse-transcriptase PCR Methods 0.000 description 1
239000012162 RNA isolation reagent Substances 0.000 description 1
241000269435 Rana <genus> Species 0.000 description 1
101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
206010039281 Rubinstein-Taybi syndrome Diseases 0.000 description 1
108020004487 Satellite DNA Proteins 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
201000001388 Smith-Magenis syndrome Diseases 0.000 description 1
201000010829 Spina bifida Diseases 0.000 description 1
208000006097 Spinal Dysraphism Diseases 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
206010042602 Supraventricular extrasystoles Diseases 0.000 description 1
206010043101 Talipes Diseases 0.000 description 1
241000255588 Tephritidae Species 0.000 description 1
208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
208000037280 Trisomy Diseases 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
206010049644 Williams syndrome Diseases 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
101710185494 Zinc finger protein Proteins 0.000 description 1
102100023597 Zinc finger protein 816 Human genes 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
206010069351 acute lung injury Diseases 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
230000032683 aging Effects 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
208000033571 alveolar capillary dysplasia with misalignment of pulmonary veins Diseases 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
210000001776 amniocyte Anatomy 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000003322 aneuploid effect Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
210000000436 anus Anatomy 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
101150010487 are gene Proteins 0.000 description 1
210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
210000001106 artificial yeast chromosome Anatomy 0.000 description 1
210000003050 axon Anatomy 0.000 description 1
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
230000008238 biochemical pathway Effects 0.000 description 1
238000003766 bioinformatics method Methods 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
238000001444 catalytic combustion detection Methods 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
210000002230 centromere Anatomy 0.000 description 1
RJYSYRSELCQCSO-UHFFFAOYSA-M cesium;2,2,2-trifluoroacetate Chemical compound [Cs+].[O-]C(=O)C(F)(F)F RJYSYRSELCQCSO-UHFFFAOYSA-M 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000005081 chemiluminescent agent Substances 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
230000008711 chromosomal rearrangement Effects 0.000 description 1
231100000005 chromosome aberration Toxicity 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
201000011228 clubfoot Diseases 0.000 description 1
230000008133 cognitive development Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
229940041967 corticotropin-releasing hormone Drugs 0.000 description 1
KLVRDXBAMSPYKH-RKYZNNDCSA-N corticotropin-releasing hormone (human) Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(C)C)C1=CNC=N1 KLVRDXBAMSPYKH-RKYZNNDCSA-N 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000007418 data mining Methods 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
238000005202 decontamination Methods 0.000 description 1
230000003588 decontaminative effect Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
230000009547 development abnormality Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
238000002592 echocardiography Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000002895 emetic Substances 0.000 description 1
238000000295 emission spectrum Methods 0.000 description 1
230000002996 emotional effect Effects 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000004920 epithelial cell of skin Anatomy 0.000 description 1
210000000632 euchromatin Anatomy 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
208000030941 fetal growth restriction Diseases 0.000 description 1
238000002060 fluorescence correlation spectroscopy Methods 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
229910052733 gallium Inorganic materials 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000003633 gene expression assay Methods 0.000 description 1
208000004104 gestational diabetes Diseases 0.000 description 1
239000011521 glass Substances 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
210000004458 heterochromatin Anatomy 0.000 description 1
210000000688 human artificial chromosome Anatomy 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000012872 hydroxylapatite chromatography Methods 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000007834 ligase chain reaction Methods 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
208000018773 low birth weight Diseases 0.000 description 1
231100000533 low birth weight Toxicity 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
238000007885 magnetic separation Methods 0.000 description 1
238000002826 magnetic-activated cell sorting Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000036244 malformation Effects 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
230000010311 mammalian development Effects 0.000 description 1
238000007726 management method Methods 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
230000006371 metabolic abnormality Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
229960000907 methylthioninium chloride Drugs 0.000 description 1
208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
238000005065 mining Methods 0.000 description 1
208000015994 miscarriage Diseases 0.000 description 1
230000026211 mitotic metaphase Effects 0.000 description 1
238000007902 molecular cytogenetic technique Methods 0.000 description 1
230000001459 mortal effect Effects 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
239000002159 nanocrystal Substances 0.000 description 1
239000013642 negative control Substances 0.000 description 1
201000008026 nephroblastoma Diseases 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
201000010193 neural tube defect Diseases 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
208000004594 persistent fetal circulation syndrome Diseases 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
230000007542 postnatal development Effects 0.000 description 1
201000011461 pre-eclampsia Diseases 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
239000011241 protective layer Substances 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
230000005180 public health Effects 0.000 description 1
208000005069 pulmonary fibrosis Diseases 0.000 description 1
239000002096 quantum dot Substances 0.000 description 1
239000010453 quartz Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
210000005132 reproductive cell Anatomy 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012340 reverse transcriptase PCR Methods 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
108010033786 ribosomal protein S4 Proteins 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000003196 serial analysis of gene expression Methods 0.000 description 1
238000010008 shearing Methods 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
238000000527 sonication Methods 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
208000000995 spontaneous abortion Diseases 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
208000035581 susceptibility to neural tube defects Diseases 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
201000002770 twin to twin transfusion syndrome Diseases 0.000 description 1
238000000870 ultraviolet spectroscopy Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
230000036642 wellbeing Effects 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Crystallography & Structural Chemistry (AREA)
Plant Pathology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA 2513028 2005-07-22 2005-07-22 Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement Abandoned CA2513028A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 2513028 CA2513028A1 (fr)	2005-07-22	2005-07-22	Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2513028 CA2513028A1 (fr)	2005-07-22	2005-07-22	Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement

Publications (1)

Publication Number	Publication Date
CA2513028A1 true CA2513028A1 (fr)	2007-01-22

Family

ID=37682424

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2513028 Abandoned CA2513028A1 (fr)	2005-07-22	2005-07-22	Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement

Country Status (1)

Country	Link
CA (1)	CA2513028A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN113674804A (zh) *	2021-09-09	2021-11-19	安吉康尔（深圳）科技有限公司	一种批量构建和筛选重组质粒的方法

2005
- 2005-07-22 CA CA 2513028 patent/CA2513028A1/fr not_active Abandoned

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN113674804A (zh) *	2021-09-09	2021-11-19	安吉康尔（深圳）科技有限公司	一种批量构建和筛选重组质粒的方法

Legal Events

Date	Code	Title	Description
2010-07-22	FZDE	Dead

Publication	Publication Date	Title
US11952623B2 (en)	2024-04-09	Simultaneous determination of aneuploidy and fetal fraction
RU2650790C2 (ru)	2018-04-17	Способы и композиции для высокомультиплексной пцр
KR102566176B1 (ko)	2023-08-10	태아 아-염색체 홀배수체 및 복제수 변이 탐지
EP3289097B1 (fr)	2020-03-18	Suppression d'erreur dans des fragments d'adn séquencés au moyen de lectures redondantes avec des indices moléculaires uniques (umi)
US20070212689A1 (en)	2007-09-13	Prenatal Diagnosis Using Cell-Free Fetal DNA in Amniotic Fluid
US20070111233A1 (en)	2007-05-17	Prenatal diagnosis using cell-free fetal DNA in amniotic fluid
US20120270739A1 (en)	2012-10-25	Method for sample analysis of aneuploidies in maternal samples
WO2009149026A2 (fr)	2009-12-10	Approches génomiques pour un traitement fœtal et un diagnostic fœtal
WO2003031656A9 (fr)	2003-09-25	Evaluation genetique du facteur de sterilite masculine
EP4428244B1 (fr)	2025-10-15	Procédés et compositions pour analyser un acide nucléique
US20060003342A1 (en)	2006-01-05	Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
US20110118125A1 (en)	2011-05-19	Neonatal salivary genomics
CA2513028A1 (fr)	2007-01-22	Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement
AU2005203357A1 (en)	2007-02-15	Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
US20130261011A1 (en)	2013-10-03	Analyzing neonatal saliva and readiness to feed
JP2007028985A (ja)	2007-02-08	発生中の胎児における遺伝子発現を決定するための羊水中の胎児ｒｎａ
US20070054289A1 (en)	2007-03-08	Identification of genes involved in fertility, ovarian function and/or fetal/newborn viability
US20250019693A1 (en)	2025-01-16	Methods and compositions for analyzing nucleic acid
WO2019016292A1 (fr)	2019-01-24	Système et procédé de dépistage et de diagnostic prénatal
CN109628585A (zh)	2019-04-16	非编码rna在诊断脓毒症中的应用
EP4724637A1 (fr)	2026-04-15	Procédés et compositions pour l'analyse d'acide nucléique
WO2007027970A2 (fr)	2007-03-08	Diagnostic prenatal utilisant un adn foetal acellulaire dans le liquide amniotique
WO2024054517A1 (fr)	2024-03-14	Procédés et compositions pour l'analyse d'acide nucléique
HK40040528A (en)	2021-07-30	Error suppression in sequenced dna fragments using redundant reads with unique molecular indices (umis)
HK40040528B (en)	2023-12-08	Error suppression in sequenced dna fragments using redundant reads with unique molecular indices (umis)

CA2513028A1 - Arn foetal dans le liquide amniotique pour analyser l'expression genetique chez le foetus en developpement - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (1)

Family

ID=37682424

Family Applications (1)

Country Status (1)

Cited By (1)

Cited By (1)

Similar Documents

Legal Events